Mast cell activation by myelin through scavenger receptor

Journal of Neuroimmunology

Volumn 200, Issue 1-2, 2008, Pages 27-40

  Medic, Nevenka ^a   Vita, Francesca ^a   Abbate, Rita ^a   Soranzo, Maria Rosa ^a   Pacor, Sabrina ^a   Fabbretti, Elsa ^b   Borelli, Violetta ^a   Zabucchi, Giuliano ^a  

^a UNIVERSITY OF TRIESTE   (Italy)

^b SISSA   (Italy)

Author keywords

EAE; Mast cells; Multiple sclerosis; Myelin

Indexed keywords

MYELIN; SCAVENGER RECEPTOR;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; DEMYELINATING DISEASE; HUMAN; HUMAN CELL; MAST CELL; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; OLIGODENDROGLIA; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RAT;

ANIMALS; ANIMALS, NEWBORN; BRAIN; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMANS; MACROPHAGES; MALE; MAST CELLS; MICE; MICROSCOPY, ELECTRON; MYELIN PROTEINS; MYELIN SHEATH; NEUTROPHILS; OLIGODENDROGLIA; RATS; RATS, WISTAR; RECEPTORS, SCAVENGER; SUPEROXIDES; TIME FACTORS; TISSUE ADHESIONS;

EID: 49849104369     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2008.05.019     Document Type: Article

References (61)

1. Aboul-Enein F., Bauer J., Klein M., Schubart A., Flugel A., Ritter T., Kawakami N., Siedler F., Linington C., Wekerle H., Lassmann H., and Bradl M. Selective and antigen-dependent effects of myelin degeneration on central nervous system inflammation. J. Neuropathol. Exp. Neurol. 63 (2004) 1284-1296
2. Archambault A.S., Sim J., Gimenez M.A., and Russell J.H. Defining antigen-dependent stages of T cell migration from the blood to the central nervous system parenchyma. Eur. J. Immunol. 35 (2005) 1076-1085
3. Barbarese E. Spatial distribution of myelin basic protein mRNA and polypeptide in quaking oligodendrocytes in culture. J. Neurosci. Res. 29 (1991) 271-281
4. Bebo Jr. B.F., Vandenbark A.A., and Offner H. Male SJL mice do not relapse after induction of EAE with PLP 139-151. J. Neurosci. Res. 45 (1996) 680-689
5. Blennerhassett M.G., and Bienenstock J. Sympathetic nerve contact causes maturation of mast cells in vitro. J. Neurobiol. 35 (1998) 173-182
6. Boggs J.M., Rangaraj G., Koshy K.M., Ackerley C., Wood D.D., and Moscarello M.A. Highly deiminated isoform of myelin basic protein from multiple sclerosis brain causes fragmentation of lipid vesicles. J. Neurosci. Res. 57 (1999) 529-535
7. Brenner T., Soffer D., Shalit M., and Levi-Schaffer F. Mast cells in experimental allergic encephalomyelitis: characterization, distribution in the CNS and in vitro activation by myelin basic protein and neuropeptides. J. Neurol. Sci. 122 (1994) 210-230
8. Brown M.A., Tanzola M.B., and Robbie-Ryan M. Mechanisms underlying mast cell influence on EAE disease course. Mol. Immunol. 38 (2002) 1373-1378
9. Brown J.M., Swindle E.J., Kushnir-Sukhov N.M., Holian A., and Metcalfe D.D. Silica-directed mast cell activation is enhanced by scavenger receptors. Am. J. Respir. Cell Mol. Biol. 36 (2007) 43-52
10. Da Costa C.C., Van der Laan L.J., Dijkstra C.D., and Brück W. The role of the mouse macrophage scavenger receptor in myelin phagocytosis. Eur. J. Neurosci. 9 (1997) 2650-2657
11. D'Agostino S., Salamone M., Di Liegro I., and Vittorelli M.L. Membrane vesicles shed by oligodendroglioma cells induce neuronal apoptosis. Int. J. Oncol. 29 (2006) 1075-1085
12. Dietsch G.N., and Hinrichs D.J. Mast cell proteases liberate stable encephalitogenic fragments from intact myelin. Cell Immunol. 135 (1991) 541-548
13. Dines K.C., and Powell H.C. Mast cell interactions with the nervous system: relationship to mechanisms of disease. J. Neuropathol. Exp. Neurol. 56 (1997) 627-640
14. Engelhardt B. Molecular mechanisms involved in T cell migration across the blood-brain barrier. J. Neural. Transm. 113 (2006) 477-485
15. Epari S., Sharma M.C., Sarkar C., Garg A., Gupta A., and Mehta V.S. Chordoid meningioma, an uncommon variant of meningioma: a clinicopathologic study of 12 cases. J. Neurooncol. 78 (2006) 263-269
16. Ercolini A.M., and Miller S.D. Mechanisms of immunopathology in murine models of central nervous system demyelinating disease. J. Immunol. 176 (2006) 3293-3298
17. Frandji P., Oskéritzian C., Cacaraci F., Lapeyre J., Peronet R., David B., Guillet J.G., and Mécheri S. Antigen-dependent stimulation by bone marrow-derived mast cells of MHC class II-restricted T cell hybridoma. J. Immunol. 151 (1993) 6318-6328
18. Frandji P., Tkaczyk C., Oskeritzian C., David B., Desaymard C., and Mécheri S. Exogenous and endogenous antigens are differentially presented by mast cells to CD4+ T lymphocytes. Eur. J. Immunol. 26 (1996) 2517-2528
19. Furuno T., Ito A Koma Y., Watabe K., Yokozaki H., Bienenstock J., Nakanishi M., and Kitamura Y. The spermatogenic Ig superfamily/synaptic cell adhesion molecule mast-cell adhesion molecule promotes interaction with nerves. J. Immunol. 174 (2005) 6934-6942
20. Greaves D.R., and Gordon S. Thematic review series: the immune system and atherogenesis. Recent insights into the biology of macrophage scavenger receptors. J. Lipid Res. 46 (2005) 11-20
21. Greenberg G., and Burnstock G. A novel cell-to-cell interaction between mast cells and other cell types and mast cells maturation. Exp. Cell Res. 147 (1983) 1-13
22. Gregory G.D., Robbie-Ryan M., Secor V.H., Sabatino Jr. J.J., and Brown M.A. Mast cells are required for optimal autoreactive T cell responses in a murine model of multiple sclerosis. Eur. J. Immunol. 35 (2005) 3478-3486
23. Greve B., Magnusson C.G., Melms A., and Weissert R. Immunogobulin isotypes reveal a predominant role of type 1 immunity in multiple sclerosis. J. Neuroimmunol. 121 (2001) 120-125
24. Horstman L.L., Jy W., Minagar A., Bidot C.J., Jimenez J.J., Alexander J.S., and Ahn Y.S. Cell-derived microparticles and exosomes in neuroinflammatory disorders. Int. Rev. Neurobiol. 79 (2007) 227-268
25. Ibrahim M.Z., Reder A.T., Lawand R., Takash W., and Sallouh-Khatib S. The mast cells of the multiple sclerosis brain. J. Neuroimmunol. 70 (1996) 131-138
26. Johnson D., Seeldrayers P.A., and Weiner H.L. The role of mast cells in demyelination. 1. Myelin proteins are degraded by mast cell proteases and myelin basic protein and P2 can stimulate mast cell degranulation. Brain Res. 44 (1988) 195-198
27. Krämer-Albers E.M., Niko Bretz N., Tenzer S., Winterstein C., Möbius W., Berger H., Klaus-Armin Nave K.A., Hansjörg Schild H., and Trotter J. Oligodendrocytes secrete exosomes containing major myelin and stress-protective proteins: trophic support for axons?. Proteomics Clin. Appl. 1 (2007) 1446-1461
28. Kuwamura M., Kanehara T., Tokuda S., Kumagai D., Yamate J., Totani T., Natane Y., Kuramoto T., and Serikawa T. Immunohistochemical and morphometrical studies on myelin breakdown in the demyelination (dmy) mutant rat. Brain Res. 1022 (2004) 110-116
29. Lin L.F., Bartlett C., and Lees M.B. Preparation and characterization of unilamellar myelin vesicles. J. Biol. Chem. 261 (1986) 16241-16246
30. Lock C., Hermans G., Pedotti R., Brendolan A., Schadt E., Garren H., Langer-Gould A., Strober S., Cannella B., Allard J., Klonowski P., Austin A., Lad N., Kaminski N., Galli J.S., Oksenberg R.J., Raine S.C., Heller R., and Steinman L. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat. Med. 8 (2002) 500-508
31. Lucchinetti C.F., Bruck W., Rodriguez M., and Lassmann H. Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis. Brain Pathol. 6 (1996) 259-274
32. Lungarella G., Menegazzi R., Gardi C., Spessotto P., de Santi M.M., Bertoncin P., Patriarca P., Calzoni P., and Zabucchi G. Identification of elastase in human eosinophils: immunolocalization, isolation, and partial characterization. Arch. Biochem. Biophys. 292 (1992) 128-135
33. Malaviya R., Twesten N.J., Ross E.A., Abraham S.N., and Pfeifer J.D. Mast cells process bacterial Ags through a phagocytic route for class I MHC presentation to T cells. J. Immunol. 156 (1996) 1490-1496
34. Mastronardi F.G., Wood D.D., Mei J., Raijmakers R., Tseveleki V., Dosch H.M., Probert L., Casaccia-Bonnefil P., and Moscarello M.A. Increased citrullination of histone H3 in multiple sclerosis brain and animal models of demyelination: a role for tumor necrosis factor-induced peptidylarginine deiminase 4 translocation. J. Neurosci. 26 (2006) 11387-11396
35. Maślińska D., Woźniak R., Kaliszek A., Schmidt-Sidor B., Lipska A., and Woolley D.E. Phenotype of mast cells in the brain tumor. Capillary hemangioblastoma. Folia Neuropathol. 37 (1999) 138-142
36. Maślińska D., Woźniak R., Kaliszek A., Schmidt-Sidor B., Lipska A., Mastronardi F.G., and Moscarello M.A. Molecules affecting myelin stability: a novel hypothesis regarding the pathogenesis of multiple sclerosis. J. Neurosci. Res. 80 (2005) 301-308
37. Mekori Y.A., and Baram D. Heterotypic adhesion-induced mast cell activation: biologic relevance in the inflammatory context. Mol. Immunol. 28 (2003) 1363-1367
38. Menegazzi R., Cramer R., Patriarca P., Scheurich P., and Dri P. Evidence that tumor necrosis factor alpha (TNF)-induced activation of neutrophil respiratory burst on biologic surfaces is mediated by the p55 TNF receptor. Blood 84 (1994) 287-293
39. Mikol D.D., Ditlow C., Usatin D., Biswas P., Kalbfleisch J., Milner A., and Calenoff E. Serum IgE reactive against small myelin protein-derived peptides is increased in multiple sclerosis patients. J. Neuroimmunol. 180 (2006) 40-49
40. Musio S., Gallo B., Scabeni S., Lapilla M., Poliani L.P., Matarese G., Ohtsu H., Galli S.J., Mantegazza R., Steinman L., and Pedotti R. A key regulatory role for histamine in experimental autoimmune encephalomyelitis: disease exacerbation in histidine decarboxylase-deficient mice. J. Immunol. 176 (2006) 17-26
41. Musse A.A., and Harauz G. Molecular "negativity" may underlie multiple sclerosis: role of the myelin basic protein family in the pathogenesis of MS. Int. Rev. Neurobiol. 79 (2007) 149-172
42. Norton W.T., and Poduslo S.E. Myelination in rat brain: method of myelin isolation. J Neurochem. 21 (1973) 749-757
43. Olsson Y. Mast cells in plaques of multiple sclerosis. Acta Neurol. Scand. 50 (1974) 611-618
44. Pedotti R., DeVoss J.J., Youssef S., Mitchell D., Wedemeyer J., Madanat R., Garren H., Fontoura P., Tsai M., Galli S.J., Sobel R.A., and Steinman L. Multiple elements of the allergic arm of the immune response modulate autoimmune demyelination. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 1867-1872
45. Piliponsky A.M., Gleich G.J., Bar I., and Levi-Shaffer F. Effects of eosinophils on mast cells: a new pathway for the perpetuation of allergic inflammation cells of Cajal. Mol. Immunol. 38 (2002) 1369-1372
46. Powers J.M., Liu Y., Moser A.B., and Moser H.W. The inflammatory myelinopathy of adreno-leukodystrophy: cells, effector molecules, and pathogenetic implications. J. Neuropathol. Exp. Neurol. 51 (1992) 630-643
47. Riccio P., Fasano A., Borenshtein N., Bleve-Zacheo T., and Kirschner D.A. Multilamellar packing of myelin modeled by lipid-bound MBP. J. Neurosci. Res. 59 (2000) 513-521
48. Rozniecki J.J., Hauser S.L., Stein M., Lincoln R., and Theoharides T.C. Elevated mast cell tryptase in cerebrospinal fluid of multiple sclerosis patients. Ann. Neurol. 37 (1995) 63-66
49. Santiago-García J., Kodama T., and Pitas R.E. The class A scavenger receptor binds to proteoglycans and mediates adhesion of macrophages to the extracellular matrix. J. Biol. Chem. 278 (2003) 6942-6946
50. Secor V.H., Secor W.A., and Brown M.A. Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis. J. Exp. Med. 191 5 (2000) 813-822 Mar 6
51. Steinman L. Optic neuritis, a new variant of experimental encephalomyelitis, a durable model for all seasons, now in its seventieth year. J. Exp. Med. 197 (2003) 1065-1071
52. Steinman L., and Zamvil S. Transcriptional analysis of targets in multiple sclerosis. Nat. Rev. Immunol. 3 (2003) 483-492
53. Steinman L., Martin R., Bernard C., Conlon P., and Oksenberg J.R. Multiple sclerosis: deeper understanding of its pathogenesis reveals new targets for therapy. Annu. Rev. Neurosci. 25 (2002) 491-505
54. Tanzola M.B., Robbie-Ryan M., Gutekunst C.A., and Brown M.A. Mast cells exert effects outside the central nervous system to influence experimental allergic encephalomyelitis disease course. J. Immunol. 171 (2003) 4385-4391
55. Toms R., Weiner H.L., and Johnson D. Identification of IgE-positive cells and mast cells in frozen sections of multiple sclerosis brains. J. Neuroimmunol. 30 (1990) 169-177
56. Trapp B.D., Pfeiffer S.E., Anitei M., and Kidd G.J. Cell biology of myelin assembly. In: Lazzarini J.W., Griffin H., Lassman K.A., Nave R.H., Miller R.H., and Trapp B.D. (Eds). Myelin Biology and Disorders vol. 1 (2004), Academic Press, San Diego,CA 29-54 Chapter 2
57. Villa I., Skokos D., Tkaczyk C., Peronet R., David B., Huerre M., and Mécheri S. Capacity of mouse mast cells to prime T cells and to induce specific antibody responses in vivo. Immunology 102 (2001) 165-172
58. Vita F., Soranzo M.R., Borelli V., Bertoncin P., and Zabucchi G. Subcellular localization of small GTPase Rab5a in resting and stimulated human neutrophils. Exp. Cell Res. 227 (1996) 367-373
59. Wang X.Y., Zarate N., Soderholm J.D., Bourgeois J.M., Liu L.W., and Huizinga J.D. Ultrastructural injury to interstitial cells of Cajal and communication with mast cells in Crohn's disease. J. Neurogastroenterol. Motil. 19 (2007) 349-364
60. Woolley D.E. Phenotype of mast cells in the brain tumor. Capillary hemangioblastoma. Folia Neuropathol. 37 (1999) 138-142
61. Zabucchi G., Menegazzi R., Soranzo M.R., and Patriarca P. Uptake of human eosinophil peroxidase by human neutrophils. Am. J. Pathol. 124 (1986) 510-518